Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
    • Internet & Telecom
  • Toggle search form
  • [Research] LigaChem Biosciences (141080) – Shinhan Securities | ConjuALL · Clinical Milestones · Big Pharma L/O / 2026-03-24 Research
  • [Research] Samsung SDI (006400) – Kyobo Securities | Gradual Loss Narrowing · Solid-State Battery Development Pipeline · Robotics Partnerships / 2026-02-03 Research
  • [Research] SK hynix (000660 / SKHY) – Yuanta | Memory Pricing · Long-Term Contracts · Earnings Stability / 2026-04-23 Research
  • [Research] LigaChem Biosciences (141080) – Yuanta Securities | Payload Chemistry · Safety Profile · Differentiation / 2025-05-22 Research
  • [Research] Samsung Electronics (005930) – Yuanta Securities | Memory Structural Up-Cycle · 1Q26 Earnings Strength · Advanced Node Leadership / 2026-01-30 Research
  • [Research] Alteogen (196170) – Daishin Securities | Keytruda Qlex Commercial Milestones · RNA Modality Expansion · Platform Re-rating / 2026-08-10 Research
  • [Research] Hanwha Ocean (042660) – Yuanta | Merchant Mix Improvement · CPSP Project Value · MASGA Catalysts / 2026-07-06 Shipbuilding
  • [Research] Samsung SDI (006400) – IBK Securities | Fully Booked North America ESS Expected · European IAA Benefits · 1Q Earnings Resilience / 2026-04-02 Research

[Research] Samsung Electronics (005930) – Hanwha | Severe Memory Shortage · HBM4 Shipment Expansion · Annual Earnings Upgrades / 2026-04-08

Posted on 4월 8, 20268월 25, 2026 By ksb220805@gmail.com

Brokerage : Hanwha Investment & Securities

Analyst : Junyoung Park (Analyst), Nau Kim (RA)

Investment Rating : BUY (Maintained)

Target Price : KRW 300,000 (Raised)

Core Momentum : Severe memory undersupply driving sharp ASP surges alongside the commercial ramp-up of HBM4 is leading to substantial upward revisions in full-year earnings forecasts.

📊 1. [Valuation & Key Financial Metrics]

Key Investment & Valuation Metrics

  • Base Stock Price (2026-04-07): KRW 196,500
  • Target Price: KRW 300,000 (Raised, +52.7% upside potential)
  • Rating: BUY Maintained (Selected as Top Pick among large-cap semiconductor stocks)
  • Valuation Methodology: Applied target P/B of 3.0x (20% discount to Micron 2026F P/B) to 2026F BPS of KRW 100,161
  • Market Cap: KRW 1,163.21 Trillion (5,919.64 million shares outstanding, 48.4% foreign ownership)

Annual Financial Outlook & Forecasts (K-IFRS Consolidated)

  • 2024(A): Revenue KRW 300.87T, Operating Profit KRW 32.73T, EBITDA KRW 75.36T, Net Profit KRW 33.62T, EPS KRW 5,433, Net Debt -KRW 93.29T (Net Cash KRW 93.29T), P/E 36.2x, P/B 3.4x, EV/EBITDA 15.6x, Dividend Yield 0.7%, ROE 9.0%
  • 2025(A): Revenue KRW 333.61T, Operating Profit KRW 43.60T, EBITDA KRW 90.21T, Net Profit KRW 44.20T, EPS KRW 7,278, Net Debt -KRW 105.39T (Net Cash KRW 105.39T), P/E 27.0x, P/B 3.1x, EV/EBITDA 12.9x, Dividend Yield 0.8%, ROE 10.9%
  • 2026(E): Revenue KRW 659.91T, Operating Profit KRW 336.88T, EBITDA KRW 388.36T, Net Profit KRW 264.71T, EPS KRW 44,735, Net Debt -KRW 287.70T (Net Cash KRW 287.70T), P/E 4.4x, P/B 2.0x, EV/EBITDA 2.5x, Dividend Yield 0.8%, ROE 48.3%
  • 2027(E): Revenue KRW 805.01T, Operating Profit KRW 463.31T, EBITDA KRW 523.17T, Net Profit KRW 362.18T, EPS KRW 61,292, Net Debt -KRW 581.78T (Net Cash KRW 581.78T), P/E 3.2x, P/B 1.3x, EV/EBITDA 1.3x, Dividend Yield 0.8%, ROE 42.6%

🚀 2. [Market Opportunities & Business Outlook]

1Q26 Results Summary & Full-Year Revisions

  • 1Q26 Performance: Revenue reached KRW 133T (+41.8% QoQ, +12% vs. consensus), and Operating Profit recorded KRW 57.2T (+185.2% QoQ, +49% vs. consensus).
  • Annual Operating Profit Outlook: Revised upward by 81% from KRW 186T to KRW 337T.

Severe Memory Shortage & Pricing Dynamics

  • DRAM ASP: Estimated to have surged +90% QoQ to approximately $1.18/Gb in 1Q26.
  • NAND ASP: Estimated to have increased +80% QoQ to approximately $0.16/GB in 1Q26.
  • Market Dynamics: With robust demand across AI and standard server applications and limited options for meaningful supply expansion, memory undersupply conditions are expected to remain pronounced and persistent.

HBM4 Technological Competitiveness

  • Commercial Shipment Ramp: Initial HBM4 shipments contributed to 1Q26 earnings, accompanied by rising demand from key North American customers.
  • Product Capabilities: Production of HBM4 operating at speeds up to 13Gbps is positioning the company as a viable solution to address customer requirements, with meaningful advances expected in the product segment.

📝 Editor’s Comment (Perspective)

The analyst views Samsung Electronics as a top semiconductor beneficiary whose earnings power is expanding substantially amid a worsening memory undersupply environment. Beyond near-term earnings beats, the overarching perspective emphasizes the sustained upward pricing momentum in DRAM and NAND under structural supply constraints, alongside strengthening market competitiveness by addressing customer requirements with high-speed (up to 13Gbps) HBM4 production.

To verify the ongoing validity of this investment thesis, key metrics to track include whether DRAM and NAND ASP upward trends persist across remaining quarters, and whether HBM4 supply to major North American customers continues to expand and contribute to earnings. These developments can be verified through upcoming quarterly earnings conference calls, official IR releases, regulatory filings on DART/KRX, and periodic financial reports.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

글 탐색

Previous Post: [Research] LIG D&A (079550) – SK Securities | Modern Warfare Leader · Limited Global CapEx · Multiple Re-rating / 2026-04-07
Next Post: [Research] Samsung Electronics (005930) – Hana Securities | Memory Pricing · LTA Structure · Earnings Upward Revision / 2026-04-08

Related Posts

  • [Research] Samsung SDI (006400) – IBK Securities | ESS Shipment Expansion · AMPC Benefits · Profit Turnaround / 2026-07-31 Research
  • [Research] LIG D&A (079550) – SK Securities | 1Q26 Earnings Beat · Overdone Correction · Global Demand Expansion / 2026-05-08 Research
  • [Research] KEPCO (015760 / KEP) – IBK Securities | Power Mix Improvement · Expanding Shareholder Returns · Nuclear Export Re-rating / 2026-02-27 Research
  • [Research] LIG D&A (079550) – Hanwha Investment & Securities | 3Q25 Review · Secured Growth Materialization · Expanding Export Share / 2025-11-07 Research
  • [Research] Samsung Electronics (005930) – Hana Securities | Unprecedented Memory ASP Surge · 4Q25 Earnings Beat · Meaningful FY26 Forecast Upgrades / 2026-01-09 Research
  • [Research] KEPCO (015760 / KEP) – Hana Securities | Raw Material Price Decline · New Reactor Commercialization · 2026 Earnings Growth / 2026-01-14 Research
  • [Research] Samsung Biologics (207940) – DS Investment & Securities | Order Recovery · Plant Ramp-up · Earnings Growth / 2026-07-24 Research
  • [Research] Samsung Electro-Mechanics (009150) – Daishin Securities | Supply Shortage · High-End Mix · Earnings Upward Cycle / 2026-07-31 Research
  • [Research] Alteogen (196170) – Hana Securities | Exclusive Biogen Licensing Deal · ~USD 40M Q1 Cumulative Upfronts · Rich Q2 Catalysts Ahead / 2026-03-26 Research
  • [Research] Samsung Electro-Mechanics (009150) – Eugene Investment & Securities | AI MLCC · ABF Substrate · Multiple Expansion / 2026-04-03 Research
  • [Research] SK hynix (000660 / SKHY) – Kyobo | AI Server Demand · Memory ASP · High-Value Product Mix / 2026-01-30 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Hyperscaler Capex · Custom HBM · Inference Memory Demand / 2026-05-04 Research
  • [Research] Samsung SDI (006400) – DS Investment & Securities | ESS Revenue Surge · 4Q26 Turnaround · Physical AI Expansion with 46-Series & All-Solid-State / 2026-02-03 Research
  • [Research] Celltrion (068270) – Yuanta Securities | New Product Mix Expansion · Pipeline Addition · Earnings Growth / 2026-07-28 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme